HSA
- Status: likely_approved
🇸🇬 Braftovi in Singapore
Braftovi (encorafenib) regulatory status in Singapore.
Marketing authorisations
HSA
- Status: likely_approved
Braftovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Braftovi approved in Singapore?
Yes. HSA has authorised it; HSA has authorised it.
Who is the marketing authorisation holder for Braftovi in Singapore?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.